Startseite › Brustkrebs › Pennsylvania › Philadelphia
Klinische Studien zu Brustkrebs in Philadelphia, PA
56 Studien zu Brustkrebs suchen Teilnehmer an Standorten in und um Philadelphia (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
Teilnehmer gesuchtPhase 3
- Consultants In Med Onco And Hema, Drexel Hill · 7 mi entfernt
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Reading Hospital McGlinn Cancer Institute at Phoenixville, Phoenixville · 22 mi entfernt
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Teilnehmer gesuchtPhase 2
- University of Pennsylvania, Abramson Cancer Center, Perelman Center for Advanced Medicine, Philadelphia
- Alliance Cancer Specialists, Horsham · 16 mi entfernt
Study of AVZO-021 in Patients With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Philadelphia
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Teilnehmer gesuchtPhase 3
- Thomas Jefferson University - Clinical Research Institute ( Site 0056), Philadelphia
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Teilnehmer gesuchtPhase 3
- Penn Medicine - Perelman Center for Advanced Medicine, Philadelphia
- Penn Medicine - Chester County Hospital, West Chester · 24 mi entfernt
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Teilnehmer gesuchtPhase 3
- Clinical Trial Site, Horsham · 16 mi entfernt
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Teilnehmer gesuchtPhase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Teilnehmer gesuchtPhase 3
- University of Pennsylvania Hospital, Philadelphia
- Thomas Jefferson University - Clinical Research Institute, Philadelphia
- Jefferson Hospital Northeast, Philadelphia
- und 1 weitere
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Teilnehmer gesuchtPhase 2
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Teilnehmer gesuchtPhase 3
- Fox Chase Cancer Center, Philadelphia
- Lankenau Medical Center, Wynnewood · 7 mi entfernt
- Consultants In Medical Oncology and Hematology, P.C., Broomall · 10 mi entfernt
- und 1 weitere
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Teilnehmer gesuchtPhase 1/2
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Teilnehmer gesuchtPhase 1/2
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
Teilnehmer gesuchtBeobachtungsstudie
- Abramson Cancer Center, Philadelphia
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Teilnehmer gesuchtPhase 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- und 11 weitere
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Sidney Kimmel Comprehensive Center at Jefferson, Philadelphia
PENN-Surveillance Markers of Utility for Recurrence After (Neo)Adjuvant Therapy for Breast Cancer
Teilnehmer gesucht
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
ATEMPT 2.0: Adjuvant T-DM1 vs TH
Teilnehmer gesuchtPhase 2
- University of Pennsylvania, Abramson Cancer Center, Philadelphia
Tai Chi for Reducing Aromatase Inhibitor-Induced Arthralgia
Teilnehmer gesucht
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Teilnehmer gesuchtPhase 2/3
- Abramson Cancer Center of The University of Pennsylvania, Philadelphia
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery
Teilnehmer gesucht
- Fox Chase Cancer Center, Philadelphia
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Teilnehmer gesuchtPhase 3
- Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital, Philadelphia
E-Mindfulness Approaches for Living After Breast Cancer
Teilnehmer gesuchtPhase 3
- UPMC Hillman Cancer Center - Part of Frick Hospital, Mount Pleasant · 8 mi entfernt
- Chester County Hospital, West Chester · 24 mi entfernt
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Teilnehmer gesuchtGesunde Freiwillige willkommen
- Thomas Jefferson University Hospital, Philadelphia
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Teilnehmer gesuchtPhase 2
- Thomas Jefferson University, Philadelphia
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Investigative Site #109, Philadelphia
Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors
Teilnehmer gesuchtPhase 1
- University of Pennsylvania, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
Teilnehmer gesucht
- Abamson Cancer Center of the University of Pennsylvania, Philadelphia
ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
Teilnehmer gesuchtPhase 2
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Teilnehmer gesuchtPhase 3
- Rittenhouse Hematology/Oncology, Philadelphia
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Hospital of the University of Pennsylvania, Philadelphia
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Teilnehmer gesuchtPhase 2
- University of Pennsylvania (U Penn), Philadelphia
Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)
Teilnehmer gesuchtFrühe Phase 1
- Hospital of the University of Pennsylvania, Philadelphia
Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)
Teilnehmer gesuchtPhase 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Teilnehmer gesuchtPhase 2
- University of Pennsylvania-Abramson Cancer Center, Philadelphia
B.Brilliant Revelation Comparision Study
Teilnehmer gesuchtBeobachtungsstudieGesunde Freiwillige willkommen
- Pennsylvania Hospital, Center for Breast Imaging, Philadelphia
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Teilnehmer gesuchtPhase 3
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- und 4 weitere
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Teilnehmer gesuchtPhase 1
- University of Pennsylvania, Philadelphia
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Teilnehmer gesuchtPhase 2
- University of Pennsylvania, Philadelphia
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Teilnehmer gesuchtPhase 1/2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients
Teilnehmer gesuchtBeobachtungsstudie
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University, Philadelphia
FES BPET-DBT in Newly Diagnosed Breast Cancer
Teilnehmer gesuchtFrühe Phase 1
- University of Pennsylvania, Philadelphia
Safe and Explainable AI
Teilnehmer gesuchtBeobachtungsstudie
- Hospital of the University of Pennsylvania, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Teilnehmer gesuchtPhase 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
CTNNA1 Familial Expansion Study
Teilnehmer gesuchtBeobachtungsstudie
- Abramson Cancer Center of the University of Pennsylvania, Philadelphia
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Teilnehmer gesuchtPhase 4
- Albert Einstein Healthcare Network, Philadelphia
[18F] F-GLN by PET/CT in Breast Cancer
Teilnehmer gesuchtPhase 1
- University of Pennsylvania, Philadelphia
Prospective Breast Cancer Biospecimen Collection
Teilnehmer gesuchtBeobachtungsstudie
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
Targeted Palliative Care Intervention for Patients With Metastatic Breast Cancer
Teilnehmer gesucht
- University of Pennsylvania, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Philadelphia
Surviving Daily Life
Teilnehmer gesuchtBeobachtungsstudie
- Thomas Jefferson University, Philadelphia
The Cancer of the Pancreas Screening-5 CAPS5)Study
Teilnehmer gesuchtPhase 3
- University of Pennsylvania, Philadelphia
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Teilnehmer gesuchtBeobachtungsstudie
- Consultants in Medical Oncology and Hematology, P.C., Broomall · 10 mi entfernt
- Alliance Cancer Specialists, Horsham · 16 mi entfernt
Role of the Immune Environment in Response to Therapy in Breast Cancer
Teilnehmer gesuchtBeobachtungsstudie
- Abramson Cancer Center, Philadelphia
Brustkrebs-Studien in anderen Städten
- New York City, NY136 Studien
- Houston, TX126 Studien
- Boston, MA112 Studien
- Nashville, TN81 Studien
- Los Angeles, CA73 Studien
- Edison, NJ68 Studien
- St. Louis, MO64 Studien
- Queens, NY64 Studien
- Durham, NC64 Studien
- Chicago, IL59 Studien
- Dallas, TX55 Studien
- Arlington, VA47 Studien
Weitere Studien in Philadelphia
- Krebs (alle Arten)59 Studien
- Nichtkleinzelliges Lungenkarzinom51 Studien
- Metastasierender Krebs46 Studien
- Prostatakrebs44 Studien
- Kolorektales Karzinom44 Studien
- Eierstockkrebs44 Studien
- Lungenkrebs36 Studien
- Akute myeloische Leukämie34 Studien
- Herzinsuffizienz31 Studien
- Endometriumkarzinom28 Studien
- Depression26 Studien
- Bauchspeicheldrüsenkrebs26 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.